GB virus type C viremia and envelope antibodies among population subsets in the Netherlands

Background and Objectives: Two new flaviviruses, hepatitis G virus and GB v irus type C (GBV-C), are possible causative agents for non-A-E hepatitis. I n this study we established the prevalence of GBV-C markers in various popu lation subsets in The Netherlands by assays for GBV-C antibodies and GBV-C nucleic acid. Materials and Methods: We tested specimens from groups of pat ients with hepatitis of various causes, intravenous drug users (IVDUs), and blood donors for GBV-C RNA (LCx(R) GBV-C assay, Abbott Laboratories), and for antibodies to the GBV-C envelope E2 protein (GBV-C anti-E2) with an enz yme immunoassay (Abbott Laboratories). Patients and donors were represented in one group only. Results: GBV-C RNA and GBV-C anti-E2 prevalence were, r espectively, 2/34 (6%) and 3/34 (9%) among patients with non-A-E hepatitis, 2/10 (20%) and 0/10 (0%) among hepatitis B virus patients, 10/40 (25%) and 19/40 (48%) among hepatitis C virus (HCV) patients, 1/8 (13%) and 0/8 (0%) among patients with autoimmune hepatitis (AIH), 24/102 (24%) and 72/102 (7 1%) among IVDUs, 1/34 (3%) and 2/34 (6%) among blood donors with indetermin ate anti-HCV recombinant immunoblot assay reactivity, and 3/250 (1.2%) and 8/250 (3.2%) among first-time blood donors. The profile of simultaneous GBV -C RNA positivity plus GBV-C anti-E2 positivity was found in 2/40 (5%) HCV patients, 4/102 (4%) IVDUs, and 1/250 (0.4%) fi rst time blood donors. Conc lusion: GBV-C infection appears not to be a major cause of non-A-E hepatiti s and AIH, but is associated with parenteral risk. The prevalence of GBV-C viremia in first time blood donors is higher than that of HCV (1.2 vs. 0.04 %), but GBV-C viremia in IVDUs is lower than HCV (24 vs. 59%). Most IVDUs h ave probably previously been exposed to GBV-C given the very high prevalenc e of GBV-C anti-E2 (71%). Most persons with GBV-C markers are GBV-C RNA-neg ative and anti-E2-confirmed positive, suggesting that GBV-C infection is tr ansient.